SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EARNINGS FLASH M impact

West Pharmaceutical net profit rises 53% year over year in Q3 2026

WST
SquawkNews Desk 1 updates Updated Oct 29, 2026, 10:11 AM UTC

Story updates

10:11:32 AM UTC
SquawkNews
OverviewOutlookResult DriversCompany press release:Key DetailsAnalyst CoverageReuters Recommended ReadsFor questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.(This story was created using…

Related stories

Basler Raises 2026 Forecast Again After Strong Nine-Month Results Basler AG said continued high incoming orders and strong preliminary nine-month results prompted another increase to its 2026 forecast. M impact | EARNINGS | Oct 29, 2026, 02:28 PM UTC Basler AG 9-month EBITDA more than doubles to EUR 61.60 million M impact | EARNINGS | Oct 29, 2026, 02:18 PM UTC Basler AG 9-month sales rise 35% to EUR 227.40 million M impact | EARNINGS | Oct 29, 2026, 02:17 PM UTC Eli Lilly Raises Revenue Forecast as Shares Surge Higher revenue guidance offsets weaker-than-expected results for its weight-loss injections and Foundayo. M impact | EARNINGS | Oct 29, 2026, 02:13 PM UTC Eli Lilly Raises Revenue Outlook as Weight-Loss Shots Offset Foundayo Sales Miss Eli Lilly raised its revenue outlook, with weight-loss shot sales offsetting a Foundayo sales miss; its shares jumped. M impact | EARNINGS | Oct 29, 2026, 02:12 PM UTC Bristol Myers Squibb Sees FY Adjusted Revenue at $49.75B-$50.25B M impact | EARNINGS | Oct 29, 2026, 02:12 PM UTC